Therapeutic potential and limitations of curcumin as antimetastatic agent
- PMID: 37141738
- DOI: 10.1016/j.biopha.2023.114758
Therapeutic potential and limitations of curcumin as antimetastatic agent
Abstract
Treatment of metastatic cancer is one of the biggest challenges in anticancer therapy. Curcumin is interesting nature polyphenolic compound with unique biological and medicinal effects, including repression of metastases. High impact studies imply that curcumin can modulate the immune system, independently target various metastatic signalling pathways, and repress migration and invasiveness of cancer cells. This review discusses the potential of curcumin as an antimetastatic agent and describes potential mechanisms of its antimetastatic activity. In addition, possible strategies (curcumin formulation, optimization of the method of administration and modification of its structure motif) to overcome its limitation such as low solubility and bioactivity are also presented. These strategies are discussed in the context of clinical trials and relevant biological studies.
Keywords: Curcumin; Metastasis; Migrastatic agents; Nanoparticles; Tumour targeting.
Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Conflict of interest statement Petr Dytrych did not have any conflict of interest. Zdeněk Kejík did not have any conflict of interest. Jan Hajduch did not have any conflict of interest. Robert Kaplánek did not have any conflict of interest. Kateřina Veselá did not have any conflict of interest. Kateřina Kučnirová did not have any conflict of interest. Markéta Skaličková did not have any conflict of interest. Anna Venhauerová did not have any conflict of interest. David Hoskovec did not have any conflict of interest. Pavel Martásek did not have any conflict of interest. Milan Jakubek did not have any conflict of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
